XML 59 R33.htm IDEA: XBRL DOCUMENT v3.8.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2017
Income Tax Disclosure [Abstract]  
Schedule of Domestic and Foreign Components of Loss before Income Taxes

The domestic and foreign components of loss before income taxes were as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2017

 

 

2016

 

 

2015

 

Domestic

 

$

(38,706

)

 

$

(27,148

)

 

$

(12,832

)

Foreign

 

$

(1,180

)

 

 

(5,493

)

 

 

(321

)

Loss before income taxes

 

$

(39,886

)

 

$

(32,641

)

 

$

(13,153

)

 

Reconciliation of U.S. Federal Statutory Income Tax Rate to Company's Effective Income Tax Rate

A reconciliation of the U.S. federal statutory income tax rate to the Company’s effective income tax rate is as follows:

 

 

 

Year Ended December 31,

 

 

 

2017

 

 

2016

 

 

2015

 

Federal statutory income tax rate

 

 

(34.0

)

 

 

(34.0

)

 

 

(34.0

)

Federal and state research and development tax credit

 

 

(3.3

)

 

 

(1.7

)

 

 

(0.9

)

State taxes, net of federal benefit

 

 

(5.3

)

 

 

(4.4

)

 

 

(5.2

)

Foreign rate differential

 

 

0.1

 

 

 

2.3

 

 

 

0.3

 

Nondeductible items

 

 

(0.1

)

 

 

4.8

 

 

 

10.2

 

Effect of US tax reform

 

 

23.8

 

 

 

 

 

 

 

Increase in deferred tax asset valuation allowance

 

 

18.8

 

 

 

33.0

 

 

 

29.6

 

Effective income tax rate

 

 

 

 

 

 

 

 

 

 

Net Deferred Tax Assets

Net deferred tax assets as of December 31, 2017 and 2016 consisted of the following (in thousands):

 

 

 

December 31,

 

 

 

2017

 

 

2016

 

Net operating loss carryforwards

 

$

21,754

 

 

$

16,406

 

Research and development tax credit carryforwards

 

 

2,022

 

 

 

697

 

Other

 

 

743

 

 

 

49

 

Total deferred tax assets

 

 

24,519

 

 

 

17,152

 

Valuation allowance

 

 

(24,519

)

 

 

(17,152

)

    Net deferred tax assets

 

$

 

 

$

 

 

Summary of Changes in Valuation Allowance for Deferred Tax Assets

Changes in the valuation allowance for deferred tax assets during the years ended December 31, 2017 and 2016 related primarily to the increase in net operating loss carryforwards, capitalized research and development expenses and research and development tax credit carryforwards and were as follows (in thousands):

 

 

 

December 31,

 

 

 

2017

 

 

2016

 

Valuation allowance as of beginning of year

 

$

(17,152

)

 

$

(6,157

)

Decreases recorded as benefit to income tax provision

 

 

 

 

 

 

Increases recorded to income tax provision

 

 

(7,367

)

 

 

(10,995

)

Valuation allowance as of end of year

 

$

(24,519

)

 

$

(17,152

)